Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (12592)	8/4/1998 4:47:00 PM
From: Mkilloran	Read Replies (1) \| Respond to of 23519

Vlad....I think you are seeing the light at the end of the tunnel ...it's good eps in the 3rd qtr...long term this will pay off for Vivus and the stockholders. And if you look further out to yr 2000 with expanded capacity in the Ireland plant...termination of the Paco contract, lower production cost and ALIBRA....the value based on yr 2000 EPS is higher than Vivus could sell the company for today. My gut feeling is that we will have a sales partner by the end of the 3rd qtr.

To: VLAD who wrote (12592)	8/4/1998 5:33:00 PM
From: Mkilloran	Respond to of 23519

vlad,,,,,just a post ref shorts and vivus what has happened and could happen again with some good news #reply-5406425

To: VLAD who wrote (12592)	8/4/1998 6:43:00 PM
From: Bhadraiah Mallampalli	Read Replies (1) \| Respond to of 23519

VLAD JNJ doesn't have much time. If they express their intention to acquire in opem market or start buying in the market, brokerages will be the first to know and they will raise the price. That is the reason they like a private negotiation with Leland. If JNJ waits till 3Q and if 3Q earnings come out better, then market will go up anyway and JNJ will end up paying much more. This is the time to negotiate favorably because the price is low. IMO. Better make it fast or else... BIBC